Abstract
Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Current Nanomedicine
Title:Nanoceria: A Novel Cytoprotective Drug Delivery Carrier
Volume: 7 Issue: 2
Author(s): Jawahar Natarajan*Sukumar Nagavishwakya
Affiliation:
- JSS College of Pharmacy, JSS University, Mysore - Pharmaceutics Ootacamund, Tamil Nadu,India
Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Abstract: Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Export Options
About this article
Cite this article as:
Natarajan Jawahar*, Nagavishwakya Sukumar, Nanoceria: A Novel Cytoprotective Drug Delivery Carrier, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187307666170208104644
DOI https://dx.doi.org/10.2174/2468187307666170208104644 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Royal Jelly Acid, 10-Hydroxy-trans-2-Decenoic Acid, as a Modulator of the Innate Immune Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Current Neuropharmacology Emerging and New Treatment Options for Knee Osteoarthritis
Current Rheumatology Reviews Fibromyalgia: The Prototypical Central Sensitivity Syndrome
Current Rheumatology Reviews Targeting the Prokineticin System to Control Chronic Pain and Inflammation
Current Medicinal Chemistry Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Current Pharmaceutical Design The Biology of p38 Kinase: A Central Role in Inflammation
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Alzheimer’s Disease-like Early-phase Brain Pathogenesis: Self-curing Amelioration of Neurodegeneration from Pro-inflammatory ‘Wounding’ to Anti-inflammatory ‘Healing’
Current Alzheimer Research Pathophysiology of the Vascular Wall and its Relevance for Cerebrovascular Disorders in Aged Rodents
Current Neurovascular Research Structure-based Pharmacophore Clustering of Multi- Conformation Proteins: Application to Identify Novel and Diverse CypD Inhibitors
Current Proteomics The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Antipsychotics as Psychosis Drugs and Neuroprotective Promoters Evaluated by Chemical QSAR - in silico and in vivo Studies
Letters in Drug Design & Discovery Cyano Acrylate Polymers in Medical Applications
Recent Patents on Materials Science Pharmacological Manipulation of Neural Progenitor Pathways In Situ: Possibilities for Neural Restoration in the Injured Adult Brain
Current Medicinal Chemistry - Central Nervous System Agents Vital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Current Neurovascular Research Neuroprotection by Methylene Blue in Cerebral Global Ischemic Injury Induced Blood-Brain Barrier Disruption and Brain Pathology: A Review
CNS & Neurological Disorders - Drug Targets Can Trehalose Prevent Neurodegeneration? Insights from Experimental Studies
Current Drug Targets